DIRK BÜSCHER,MANUEL ÁNGEL GONZÁLEZ DE LA PEÑA,MARIO DELGADO MORA
申请号:
PT06777197
公开号:
PT1926813T
申请日:
2006.09.22
申请国别(地区):
PT
年份:
2016
代理人:
摘要:
The present invention provides a population of connective tissue derived cells that respond to interferon-gamma (IFN-³) by expressing indolamine-2,3-dioxygenase (IDO) for use in preventing, treating or ameliorating one or more symptoms associated with disorders in which modulation of a subjects immune system is beneficial, including, but not limited to, autoimmune diseases, inflammatory disorders, and immunologically mediated diseases including rejection of transplanted organs and tissues.